{"cluster": 38, "subcluster": 5, "abstract_summ": "Management of lung transplant recipients can be particularly challenging given high levels of maintenance immunosuppression, high incidence of rejection, constant exposure of the graft to the external environment, and diagnostic uncertainty in patients with respiratory symptoms.We report a single-center experience using universal SARS-CoV-2 screening for all inpatients and newly admitted patients to an Organ Transplant Unit located in a region with significantly high community-based transmission.Some reports suggest that transplant patients may not be at higher risk if proper social distancing and preventive measures are employed.During this novel coronavirus disease 2019 pandemic, preserving \"clean areas\" in hospitals assisting organ transplant recipients is key to protect them and to preserve transplantation activity.Recommendations for the care of lung transplant patients during the COVID-19 pandemic are discussed and will likely change as the pandemic evolves.", "title_summ": "COVID-19 infection in solid organ transplant recipients: a single center experience with patients immediately after transplantation.COVID\u201019 in Lung Transplant RecipientsLessons from SARS-CoV-2 screening in a Brazilian Organ Transplant Unit.COVID-19 and lung transplant patients.", "title_abstract_phrases": "During this novel coronavirus disease 2019 pandemic, preserving \"clean areas\" in hospitals assisting organ transplant recipients is key to protect them and to preserve transplantation activity.In our transplant center, infection with SARS-Cov-2 virus was confirmed in 4 organ transplant recipients (3 kidney and 1 liver transplant recipients) during their early post-transplant hospital stay.Some reports suggest that transplant patients may not be at higher risk if proper social distancing and preventive measures are employed.COVID\u201019 in Lung Transplant RecipientsSolid organ transplant recipients are considered at a high risk for severe COVID\u201019 disease due to chronic immunosuppression, though their risk compared to that of the general population remains unclear.Management of lung transplant recipients can be particularly challenging given high levels of maintenance immunosuppression, high incidence of rejection, constant exposure of the graft to the external environment, and diagnostic uncertainty in patients with respiratory symptoms."}